IP 254 Pill - yellow capsule/oblong, 17mm
Pill with imprint IP 254 is Yellow, Capsule/Oblong and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Gastric Ulcer Maintenance Treatment; Duodenal Ulcer Prophylaxis; Cutaneous Mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 254
Ranitidine Hydrochloride
- Imprint
- IP 254
- Strength
- 300 mg
- Color
- Yellow
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0725 (Discontinued) | AvKare, Inc. |
| 53746-0254 (Discontinued) | Amneal Pharmaceuticals LLC |
| 65162-0254 (Discontinued) | Amneal Pharmaceuticals LLC |
See also:
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.